Agennix hires Christine Boisclair as senior VP of regulatory affairs
This article was originally published in Scrip
Agennix has appointed Christine Boisclair senior vice-president for global regulatory affairs, reporting to Dr Rajesh Malik, the company's chief medical officer. Ms Boisclair joins Agennix from OSI Pharmaceuticals where she most recently served as vice-president of regulatory affairs.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.